Gene therapy for disc degeneration

Bibliography

• LUO X, PIETROBON R, SUN SX, LIU GG, HEY L: Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine (2004) 29(1):79-86.
   PubMed Web of Science ®Google Scholar
• LIVELY MW: Sports medicine approach to low back pain. South Med. J. (2002) 95(6):642-646.
   PubMed Web of Science ®Google Scholar
• HART LG, DEYO RA, CHERKIN DC: Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a US national survey. Spine (1995) 20(1):11-19.
   PubMed Web of Science ®Google Scholar
• BATTIE MC, VIDEMAN T, PARENT E: Lumbar disc degeneration: epidemiology and genetic influences. Spine (2004) 29(23):2679-2690.
   PubMed Web of Science ®Google Scholar
• VIDEMAN T, LEPPAVUORI J, KAPRIO J et al.: Intragenic polymorphisms of the vitamin D receptor gene associated with intervertebral disc degeneration. Spine (1998) 23(23):2477-2485.
   PubMed Web of Science ®Google Scholar
• ANNUNEN S, PAASSILTA P, LOHINIVA J et al.: An allele of COL9A2 associated with intervertebral disc disease. Science (1999) 285(5426):409-412.
   PubMed Web of Science ®Google Scholar
• PAASSILTA P, LOHINIVA J, GORING HH et al.: Identification of a novel common genetic risk factor for lumbar disk disease. JAMA (2001) 285(14):1843-1849.
   PubMed Web of Science ®Google Scholar
• TAKAHASHI M, HARO H, WAKABAYASHI Y et al.: The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J. Bone Joint Surg. Br. (2001) 83(4):491-495.
   PubMed Web of Science ®Google Scholar
• KAWAGUCHI Y, OSADA R, KANAMORI M et al.: Association between an aggrecan gene polymorphism and lumbar disc degeneration. Spine (1999) 24(23):2456-2460.
   PubMed Web of Science ®Google Scholar
• VIDEMAN T, SAARELA J, KAPRIO J et al.: Most of the 28 studied candidate genes were associated with the degenerative MRI findings in the intervertebral discs. International Society of the Study of the Lumbar Spine. Bergen, Norway (2006):21.
   Google Scholar
• BUCKWALTER JA: Aging and degeneration of the human intervertebral disc. Spine (1995) 20(11):1307-1314.
   PubMed Web of Science ®Google Scholar
• PEARCE RH, GRIMMER BJ, ADAMS ME: Degeneration and the chemical composition of the human lumbar intervertebral disc. J. Orthop. Res. (1987) 5(2):198-205.
   PubMed Web of Science ®Google Scholar
• URBAN JP, MCMULLIN JF: Swelling pressure of the inervertebral disc: influence of proteoglycan and collagen contents. Biorheology (1985) 22(2):145-157.
   PubMed Web of Science ®Google Scholar
• URBAN JP, MCMULLIN JF: Swelling pressure of the lumbar intervertebral discs: influence of age, spinal level, composition, and degeneration. Spine (1988) 13(2):179-187.
   PubMed Web of Science ®Google Scholar
• BUTLER D, TRAFIMOW JH, ANDERSSON GB, MCNEILL TW, HUCKMAN MS: Discs degenerate before facets. Spine (1990) 15(2):111-113.
   PubMed Web of Science ®Google Scholar
• MOORE RJ, CROTTI TN, OSTI OL, FRASER RD, VERNON-ROBERTS B: Osteoarthrosis of the facet joints resulting from anular rim lesions in sheep lumbar discs. Spine (1999) 24(6):519-525.
   PubMed Web of Science ®Google Scholar
• VERNON-ROBERTS B: The Biology of the Intervertebral Disc. Vernon-Roberts B (Ed.), CRC Press, Boca Raton, FL, USA (1988):73-119.
   Google Scholar
• URBAN JP, SMITH S, FAIRBANK JC: Nutrition of the intervertebral disc. Spine (2004) 29(23):2700-2709.
   PubMed Web of Science ®Google Scholar
• MASUDA K, OEGEMA TR JR, AN HS: Growth factors and treatment of intervertebral disc degeneration. Spine (2004) 29(23):2757-2769.
   PubMed Web of Science ®Google Scholar
• THOMPSON JP, OEGEMA TR JR, BRADFORD DS: Stimulation of mature canine intervertebral disc by growth factors. Spine (1991) 16(3):253-260.
   PubMed Web of Science ®Google Scholar
• TAKEGAMI K, THONAR EJ, AN HS, KAMADA H, MASUDA K: Osteogenic protein-1 enhances matrix replenishment by intervertebral disc cells previously exposed to interleukin-1. Spine (2002) 27(12):1318-1325.
   PubMed Web of Science ®Google Scholar
• LI J, YOON ST, HUTTON WC: Effect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells. J. Spinal Disord. Tech. (2004) 17(5):423-428.
   PubMed Web of Science ®Google Scholar
• KIM DJ, MOON SH, KIM H et al.: Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells. Spine (2003) 28(24):2679-2684.
   PubMed Web of Science ®Google Scholar
• OSADA R, OHSHIMA H, ISHIHARA H et al.: Autocrine/paracrine mechanism of insulin-like growth factor-1 secretion, and the effect of insulin-like growth factor-1 on proteoglycan synthesis in bovine intervertebral discs. J. Orthop. Res. (1996) 14(5):690-699.
   PubMed Web of Science ®Google Scholar
• AN HS, TAKEGAMI K, KAMADA H et al.: Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine (2005) 30(1):25-31; discussion 31-22.
   PubMed Web of Science ®Google Scholar
• MASUDA K, IMAI Y, OKUMA M et al.: Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine (2006) 31(7):742-754.
   PubMed Web of Science ®Google Scholar
• WINN SR, ULUDAG H, HOLLINGER JO: Carrier systems for bone morphogenetic proteins. Clin. Orthop. Relat. Res. (1999) (367 Suppl.):S95-S106.
   Google Scholar
• HACEIN-BEY-ABINA S, VON KALLE C, SCHMIDT M et al.: LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 302(5644):415-419.
   PubMed Web of Science ®Google Scholar
• ROBBINS PD, TAHARA H, GHIVIZZANI SC: Viral vectors for gene therapy. Trends Biotech.nol. (1998) 16(1):35-40.
   PubMed Web of Science ®Google Scholar
• WEHLING P, SCHULITZ KP, ROBBINS PD, EVANS CH, REINECKE JA: Transfer of genes to chondrocytic cells of the lumbar spine. Proposal for a treatment strategy of spinal disorders by local gene therapy. Spine (1997) 22(10):1092-1097.
   PubMed Web of Science ®Google Scholar
• YANG Y, NUNES FA, BERENCSI K et al.: Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA (1994) 91(10):4407-4411.
   PubMed Web of Science ®Google Scholar
• NITA I, GHIVIZZANI SC, GALEA-LAURI J et al.: Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum. (1996) 39(5):820-828.
   PubMed Web of Science ®Google Scholar
• SAWCHUK SJ, BOIVIN GP, DUWEL LE et al.: Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenovirus-mediated in vivo gene transfer to mouse synovium. Hum. Gene Ther. (1996) 7(4):499-506.
   PubMed Web of Science ®Google Scholar
• MCCOY RD, DAVIDSON BL, ROESSLER BJ, HUFFNAGLE GB, SIMON RH: Expression of human interleukin-1 receptor antagonist in mouse lungs using a recombinant adenovirus: effects on vector-induced inflammation. Gene Ther. (1995) 2(7):437-442.
   PubMed Web of Science ®Google Scholar
• NISHIDA K, MOON SH, GILBERTSON LG, KANG JD: Immune-privilege of the intervertebral disc: long-term transgene expression following direct adenovirus mediated gene transfer. International Society of the Study of the Lumbar Spine. Adelaide, Australia (2000):0069.
   Google Scholar
• DRIESSE MJ, ESANDI MC, KROS JM et al.: Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity. Gene Ther. (2000) 7(16):1401-1409.
   PubMed Web of Science ®Google Scholar
• WALLACH CJ, KIM JS, SOBAJIMA S et al.: Safety assessment of intradiscal gene transfer: a pilot study. Spine J. (2006) 6(2):107-112.
   PubMedGoogle Scholar
• AFIONE SA, WANG J, WALSH S, GUGGINO WB, FLOTTE TR: Delayed expression of adeno-associated virus vector DNA. Intervirology (1999) 42(4):213-220.
   PubMed Web of Science ®Google Scholar
• LAI CM, LAI YK, RAKOCZY PE: Adenovirus and adeno-associated virus vectors. DNA Cell Biol. (2002) 21(12):895-913.
   PubMed Web of Science ®Google Scholar
• LATTERMANN C, OXNER WM, XIAO X et al.: The adeno associated viral vector as a strategy for intradiscal gene transfer in immune competent and pre-exposed rabbits. Spine (2005) 30(5):497-504.
   PubMed Web of Science ®Google Scholar
• XIAO X, LI J, SAMULSKI RJ: Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. (1996) 70(11):8098-8108.
   PubMed Web of Science ®Google Scholar
• DUAN D, YUE Y, YAN Z, MCCRAY PB JR, ENGELHARDT JF: Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum. Gene Ther. (1998) 9(18):2761-2776.
   PubMed Web of Science ®Google Scholar
• GAO G, VANDENBERGHE LH, WILSON JM: New recombinant serotypes of AAV vectors. Curr. Gene Ther. (2005) 5(3):285-297.
   Google Scholar
• NISHIDA K, DOITA M, TAKADA T et al.: Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy. Spine (2006) 31(13):1415-1419.
   PubMed Web of Science ®Google Scholar
• NISHIDA K, KAKUTANI K, DOITA M et al.: Down regulation of Fas ligand expression in nucleus pulposus cells in vitro mediated by RNA interference: successful gene silencing of endogenous gene. International Society of the Study of the Lumbar Spine. New York, NY, USA (2005):112.
   Google Scholar
• KAKUTANI K, NISHIDA K, DOITA M et al.: DNA vector based RNA interference in nucleus pulposus cells in vitro. International Society of the Study of the Lumbar Spine. New York, NY, USA (2005):111.
   Google Scholar
• NISHIDA K, KANG JD, SUH JK et al.: Adenovirus-mediated gene transfer to nucleus pulposus cells. Implications for the treatment of intervertebral disc degeneration. Spine (1998) 23(22):2437-2442; discussion 2443.
   PubMed Web of Science ®Google Scholar
• NISHIDA K, KANG JD, GILBERTSON LG et al.: Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine (1999) 24(23):2419-2425.
   PubMed Web of Science ®Google Scholar
• MOON SH, GILBERTSON LG, NISHIDA K et al.: Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: implications for the clinical management of intervertebral disc disorders. Spine (2000) 25(20):2573-2579.
   PubMed Web of Science ®Google Scholar
• MOON SH, NISHIDA K, GILBERTSON LG, ROBBINS PD, KANG JD: Proteoglycan synthesis in human intervertebral disc cells cultured in alginate beads; exogenous TGF-beta1 versus adenovirus-mediated gene transfer of TGF beta1 cDNA. Orthopaedic Research Society. Orlando, FL, USA (2000):1061.
   Google Scholar
• MOON SH, NISHIDA K, GILBERTSON LG, ROBBINS PD, KANG JD: Biologic response of human intervertebral disc cell to gene therapy cocktail. Orthopaedic Research Society. San Francisco, CA, USA (2001):0295.
   Google Scholar
• ZHANG Y, LI Z, THONAR EJ et al.: Transduced bovine articular chondrocytes affect the metabolism of cocultured nucleus pulposus cells in vitro: implications for chondrocyte transplantation into the intervertebral disc. Spine (2005) 30(23):2601-2607.
   PubMed Web of Science ®Google Scholar
• HANDA T, ISHIHARA H, OHSHIMA H et al.: Effects of hydrostatic pressure on matrix synthesis and matrix metalloproteinase production in the human lumbar intervertebral disc. Spine (1997) 22(10):1085-1091.
   PubMed Web of Science ®Google Scholar
• KANEMOTO M, HUKUDA S, KOMIYA Y, KATSUURA A, NISHIOKA J: Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 human intervertebral discs. Spine (1996) 21(1):1-8.
   PubMed Web of Science ®Google Scholar
• SOBAJIMA S, SHIMER AL, CHADDERDON RC et al.: Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. Spine J. (2005) 5(1):14-23.
   PubMedGoogle Scholar
• WALLACH CJ, SOBAJIMA S, WATANABE Y et al.: Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine (2003) 28(20):2331-2337.
   PubMed Web of Science ®Google Scholar
• STUDER RK, ABOKA AM, IUCU CT, GILBERTSON LG, KANG JD: Human intervertebral disc cell matrix protein synthesis restored by p38 MAPK inhibition. Orthopaedic Research Society. Chicago, IL, USA (2006):0013.
   Google Scholar
• STUDER RK, GILBERTSON LG, GEORGESCU HI et al.: p38 MAPK inhibition modulates rabbits intervertebral disc cell response to IL-1. Orthopaedic Research Society. Chicago, IL, USA (2006):1200.
   Google Scholar
• PAUL R, HAYDON RC, CHENG H et al.: Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine (2003) 28(8):755-763.
   PubMed Web of Science ®Google Scholar
• BODEN SD, LIU Y, HAIR GA et al.: LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. Endocrinology (1998) 139(12):5125-5134.
   PubMed Web of Science ®Google Scholar
• BODEN SD, TITUS L, HAIR G et al.: Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine (1998) 23(23):2486-2492.
   PubMed Web of Science ®Google Scholar
• YOON ST, PARK JS, KIM KS et al.: ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine (2004) 29(23):2603-2611.
   PubMed Web of Science ®Google Scholar
• SOBAJIMA S, KOMPEL JF, KIM JS et al.: A slowly progressive and reproducible animal model of intervertebral disc degeneration characterized by MRI, X-ray, and histology. Spine (2005) 30(1):15-24.
   PubMed Web of Science ®Google Scholar
• SHIMER AL, SOBAJIMA S, CHADDERDON RC et al.: BMP-2 gene transfer favorably alters course of disc degeneration in rabbit model. Orthpaedic Research Society. Washington DC, USA (2005):0183.
   Google Scholar
• MARSHALL E: Gene therapy death prompts review of adenovirus vector. Science (1999) 286(5448):2244-2245.
   PubMed Web of Science ®Google Scholar
• KIM DJ, SOBAJIMA S, WALLACH CJ et al.: A profile of safety: the potential hazards of intradiscal gene therapy. Orthopaedic Research Society. Washington DC, ME (2005):0037.
   Google Scholar
• VADALA G, HUBERT MG, SMITH L et al.: Regulation of transgene expression using an inducible system for improved safety of intradiscal gene therapy. International Society of the Study of the Lumbar Spine. Bergen, Norway (2006).
   Google Scholar
• ALP E, KOC RK, DURAK AC et al.: Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]. BMC Infect. Dis. (2006) 6:72.
   PubMedGoogle Scholar
• NAS K, GUR A, KEMALOGLU MS et al.: Management of spinal brucellosis and outcome of rehabilitation. Spinal Cord (2001) 39(4):223-227.
   PubMed Web of Science ®Google Scholar
• VAVERKA M, PETRZELOVA J: [Penetration of antibiotics into the intervertebral disk]. Acta Chir. Orthop. Traumatol. Cech. (1991) 58(1-2):98-103.
   PubMedGoogle Scholar
• GRAHAM LD: Ecdysone-controlled expression of transgenes. Expert Opin. Biol. Ther. (2002) 2(5):525-535.
   PubMed Web of Science ®Google Scholar
• TANG YL, TANG Y, ZHANG YC et al.: Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system. Hypertension (2004) 43(4):746-751.
   PubMed Web of Science ®Google Scholar
• MASUDA K, MIYAMOTO H, AN H, URBAN JP, AKEDA K: Low oxygen tension and OP-1 synergistically enhance anabolic effect on extracellular metrix production by bovine intervertebral disc cells in normal and poor nutritional conditions. North American Spine Society. Seattle, WA, USA (2006):48.
   Google Scholar
• BARTELS EM, FAIRBANK JC, WINLOVE CP, URBAN JP: Oxygen and lactate concentrations measured in vivo in the intervertebral discs of patients with scoliosis and back pain. Spine (1998) 23(1):1-7; discussion 8.
   PubMed Web of Science ®Google Scholar
• URBAN MR, FAIRBANK JC, ETHERINGTON PJ et al.: Electrochemical measurement of transport into scoliotic intervertebral discs in vivo using nitrous oxide as a tracer. Spine (2001) 26(8):984-990.
   PubMed Web of Science ®Google Scholar
• FERBER D: Gene therapy. Safer and virus-free? Science (2001) 294(5547):1638-1642.
   PubMed Web of Science ®Google Scholar